开始降压治疗后肾功能快速下降是有益的迹象。
Early Rapid Decline in Kidney Function as a Beneficial Sign After Starting Antihypertensive Medication.
机构信息
Department of Nephrology and Kuratorium for Dialysis and Transplantation Renal Unit Hospital St. Georg Martin-Luther-University Halle/Wittenberg Leipzig Germany.
出版信息
J Am Heart Assoc. 2019 Jun 4;8(11):e013145. doi: 10.1161/JAHA.119.013145. Epub 2019 Jun 1.
Abstract
See Article Cooper et al.
摘要
见 Cooper 等人的文章。
相似文献
1
Early Rapid Decline in Kidney Function as a Beneficial Sign After Starting Antihypertensive Medication.开始降压治疗后肾功能快速下降是有益的迹象。
J Am Heart Assoc. 2019 Jun 4;8(11):e013145. doi: 10.1161/JAHA.119.013145. Epub 2019 Jun 1.
2
Renal protection in hypertensive patients: selection of antihypertensive therapy.高血压患者的肾脏保护：抗高血压治疗的选择
Drugs. 2005;65 Suppl 2:29-39. doi: 10.2165/00003495-200565002-00005.
3
Use of renin-angiotensin inhibitors in people with renal artery stenosis.肾动脉狭窄患者使用肾素 - 血管紧张素抑制剂。
Clin J Am Soc Nephrol. 2014 Jul;9(7):1199-206. doi: 10.2215/CJN.11611113. Epub 2014 Jun 5.
4
Drug therapy of renovascular hypertension.肾血管性高血压的药物治疗
Drugs. 1993 Jun;45(6):895-909. doi: 10.2165/00003495-199345060-00003.
5
Renal function in hypertension.
Am J Med. 1988 Jan 29;84(1B):69-75.
6
7
Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy.糖尿病肾病中肾素-血管紧张素系统的单药与联合阻断治疗（血管紧张素转换酶抑制剂和/或血管紧张素II受体阻滞剂）
Curr Opin Nephrol Hypertens. 2004 May;13(3):319-24. doi: 10.1097/00041552-200405000-00009.
8
Physiologic evidence of renoprotection by antihypertensive therapy.
Curr Opin Cardiol. 2005 Jul;20(4):290-5. doi: 10.1097/01.hco.0000161226.67093.e3.
9
Prospective studies of diagnosis and intervention: the Dutch experience.诊断与干预的前瞻性研究：荷兰的经验
Semin Nephrol. 2000 Sep;20(5):463-73.
本文引用的文献
1
Early Rapid Decline in Kidney Function in Medically Managed Patients With Atherosclerotic Renal Artery Stenosis.经医学治疗的动脉粥样硬化性肾动脉狭窄患者肾功能的早期快速下降。
J Am Heart Assoc. 2019 Jun 4;8(11):e012366. doi: 10.1161/JAHA.119.012366. Epub 2019 Jun 1.
2
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.起始血管紧张素转换酶抑制剂治疗后血清肌酐的急性升高及其对 2 型糖尿病主要临床结局的影响。
Hypertension. 2019 Jan;73(1):84-91. doi: 10.1161/HYPERTENSIONAHA.118.12060.
3
The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.在慢性肾脏病患者中通过抑制钠-葡萄糖协同转运蛋白2改善心肾结局的潜力：依帕列净治疗慢性肾脏病（EMPA-KIDNEY）研究的理论依据
Clin Kidney J. 2018 Dec;11(6):749-761. doi: 10.1093/ckj/sfy090. Epub 2018 Oct 25.
4
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.达格列净与 2 型糖尿病患者的心血管结局
N Engl J Med. 2019 Jan 24;380(4):347-357. doi: 10.1056/NEJMoa1812389. Epub 2018 Nov 10.
5
A randomized, multi-center, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with hemodynamically relevant atherosclerotic renal artery stenosis (RADAR) - one-year results of a pre-maturely terminated study.一项比较最佳药物治疗与最佳药物治疗加肾动脉支架置入术对血流动力学相关动脉粥样硬化性肾动脉狭窄患者疗效的随机、多中心、前瞻性研究（RADAR）——一项提前终止研究的一年结果
Trials. 2017 Aug 14;18(1):380. doi: 10.1186/s13063-017-2126-x.
6
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.卡格列净与 2 型糖尿病的心血管和肾脏事件。
N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12.
7
Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.CORAL试验中动脉粥样硬化性肾动脉狭窄支架置入术对估算肾小球滤过率的影响及临床事件的预测因素
Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1180-1188. doi: 10.2215/CJN.10491015. Epub 2016 May 25.
8
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.恩格列净：在 2 型糖尿病中的心血管结局和死亡率。
N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17.
9
Stenting and medical therapy for atherosclerotic renal-artery stenosis.经皮腔内血管成形术及药物治疗动脉粥样硬化性肾动脉狭窄
N Engl J Med. 2014 Jan 2;370(1):13-22. doi: 10.1056/NEJMoa1310753. Epub 2013 Nov 18.
10
An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function.在使用氯沙坦治疗期间估计肾小球滤过率的急剧下降预示着长期肾功能下降速度较慢。
Kidney Int. 2011 Aug;80(3):282-7. doi: 10.1038/ki.2011.79. Epub 2011 Mar 30.
Zotero 插件